New insider activity at Cohen & Steers ( (CNS) ) has taken place on October 22, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
EC Robert Hamilton Steers has made a significant investment by purchasing 40,539 shares of Cohen & Steers stock, valued at a total of $2,846,316.
Recent Updates on CNS stock
In the last 24 hours, Cohen & Steers has seen a notable development with BofA raising its price target from $68 to $71, despite maintaining an Underperform rating. This adjustment follows the company’s better-than-expected Q3 results, which included an EPS beat and an increase in 2025 G&A growth guidance to 9%. However, concerns remain due to elevated redemptions and the ongoing challenge of high-interest rates, particularly affecting the real estate sector. Additionally, Cohen & Steers reported a preliminary AUM of $90.9B as of September 30, 2025, reflecting market appreciation but also facing net outflows. The firm’s strategic focus on real assets and alternative income continues to be a key aspect of its growth outlook.
Spark’s Take on CNS Stock
According to Spark, TipRanks’ AI Analyst, CNS is a Outperform.
Cohen & Steers’ overall stock score reflects strong financial performance and positive earnings call highlights, tempered by technical indicators suggesting bearish trends and challenges in cash flow management. The valuation is reasonable, with a solid dividend yield supporting the score.
To see Spark’s full report on CNS stock, click here.
More about Cohen & Steers
YTD Price Performance: -21.58%
Average Trading Volume: 257,887
Technical Sentiment Signal: Hold
Current Market Cap: $3.6B